Protagonist Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€80.50
Target price
31.12.25
€40.00
Performance (%)
-
End price
31.08.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -1.829% | -1.829% | 269.266% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
According to BiotechBee what are the pros and cons of Protagonist Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Buy mit Kursziel 40,0
In the thread Trading Protagonist Therapeutics Inc
Buy beendet

